The global Renal Cyst Treatment Market is poised for significant expansion, growing from an estimated USD 203.2 million in ...

PKD is mainly caused by mutations in the PKD1 and PKD2 genes, affecting polycystin proteins. Disrupted signaling pathways, like cAMP and vasopressin, are major drivers of cyst growth. Tolvaptan is ...

Polycystic kidney disease (PKD) is a genetic disorder marked by the growth of many fluid-filled sacs (cysts) in your kidneys. These cysts can grow to replace normal kidney tissue over time, leading to ...

"Helex secures $3.5m to advance kidney disease therapies" was originally created and published by Pharmaceutical Technology, ...

Autosomal dominant polycystic kidney disease (ADPKD), the most common form of polycystic kidney disease, can lead to kidney enlargement and eventual loss of function. The disease affects more than 12 ...

People with polycystic kidney disease (PKD) could benefit from a moderate increase in water intake, according to new research. People with polycystic kidney disease (PKD) could benefit from a moderate ...

Researchers from Westmead Hospital and the Westmead Institute for Medical Research in Australia are developing a safe, cheap and effective method to treat polycystic kidney disease; drinking the right ...

A research project has successfully reproduced the pathogenesis of autosomal dominant polycystic kidney disease (ADPKD) from human iPS cells in vitro. Although cysts derived from renal tubules have ...